2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
100
-1.1%
53,55
5 355
USD
|
100
-1.1%
|
53,55
|
5 355
USD
|
|
2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
500
-5.2%
52,63
26 314
USD
|
500
-5.2%
|
52,63
|
26 314
USD
|
|
2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
10 481
-52.4%
51,48
539 542
USD
|
10 481
-52.4%
|
51,48
|
539 542
USD
|
|
2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
7 087
-26.1%
50,99
361 346
USD
|
7 087
-26.1%
|
50,99
|
361 346
USD
|
|
2024-04-18 |
2024-04-16 |
VP
Vente planifiée
|
Ware Olivia C
Administrateur non-exécutif
|
2 612
-100.0%
56,03
146 353
USD
|
2 612
-100.0%
|
56,03
|
146 353
USD
|
|
2024-04-18 |
2024-04-16 |
VP
Vente planifiée
|
Ware Olivia C
Administrateur non-exécutif
|
6 790
-72.2%
55,36
375 907
USD
|
6 790
-72.2%
|
55,36
|
375 907
USD
|
|
2024-04-03 |
2024-04-01 |
VP
Vente planifiée
|
Elghandour Rami
SEE REMARKS
Administrateur exécutif
|
2 711
-3.8%
68,42
185 476
USD
|
2 711
-3.8%
|
68,42
|
185 476
USD
|
|
2024-04-03 |
2024-04-01 |
VP
Vente planifiée
|
Elghandour Rami
SEE REMARKS
Administrateur exécutif
|
5 456
-7.0%
67,58
368 731
USD
|
5 456
-7.0%
|
67,58
|
368 731
USD
|
|
2024-04-03 |
2024-04-01 |
VP
Vente planifiée
|
Elghandour Rami
SEE REMARKS
Administrateur exécutif
|
14 919
-16.2%
66,67
994 680
USD
|
14 919
-16.2%
|
66,67
|
994 680
USD
|
|
2024-03-26 |
2024-03-26 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
861
-8.8%
70,19
60 431
USD
|
861
-8.8%
|
70,19
|
60 431
USD
|
|
2024-03-26 |
2024-03-26 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
2 034
-17.2%
69,36
141 079
USD
|
2 034
-17.2%
|
69,36
|
141 079
USD
|
|
2024-03-26 |
2024-03-26 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
2 555
-17.8%
68,55
175 138
USD
|
2 555
-17.8%
|
68,55
|
175 138
USD
|
|
2024-03-26 |
2024-03-22 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
1 000
-10.1%
72,25
72 247
USD
|
1 000
-10.1%
|
72,25
|
72 247
USD
|
|
2024-03-26 |
2024-03-22 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
4 333
-30.4%
71,36
309 211
USD
|
4 333
-30.4%
|
71,36
|
309 211
USD
|
|
2024-03-26 |
2024-03-22 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
25 975
-64.5%
70,13
1 821 697
USD
|
25 975
-64.5%
|
70,13
|
1 821 697
USD
|
|
2024-03-26 |
2024-03-22 |
VP
Vente planifiée
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
10 057
-20.0%
69,59
699 911
USD
|
10 057
-20.0%
|
69,59
|
699 911
USD
|
|
2024-03-25 |
2024-03-21 |
V
Vente
|
Carroll Jill
Administrateur non-exécutif
|
504 263
-25.4%
70,55
35 575 755
USD
|
504 263
-25.4%
|
70,55
|
35 575 755
USD
|
|
2024-03-18 |
2024-03-18 |
VP
Vente planifiée
|
Gilson Michelle
CHIEF FINANCIAL OFFICER
Dirigeant
|
3 043
-24.3%
69,73
212 192
USD
|
3 043
-24.3%
|
69,73
|
212 192
USD
|
|
2024-03-18 |
2024-03-18 |
VP
Vente planifiée
|
Gilson Michelle
CHIEF FINANCIAL OFFICER
Dirigeant
|
3 782
-23.2%
69,03
261 063
USD
|
3 782
-23.2%
|
69,03
|
261 063
USD
|
|
2024-03-18 |
2024-03-15 |
VP
Vente planifiée
|
Ware Olivia C
Administrateur non-exécutif
|
3 337
-100.0%
70,99
236 881
USD
|
3 337
-100.0%
|
70,99
|
236 881
USD
|
|
2024-03-18 |
2024-03-15 |
VP
Vente planifiée
|
Ware Olivia C
Administrateur non-exécutif
|
3 763
-53.0%
70,36
264 768
USD
|
3 763
-53.0%
|
70,36
|
264 768
USD
|
|
2024-03-18 |
2024-03-15 |
VP
Vente planifiée
|
Ware Olivia C
Administrateur non-exécutif
|
1 900
-21.1%
69,44
131 932
USD
|
1 900
-21.1%
|
69,44
|
131 932
USD
|
|
2024-02-12 |
2024-02-12 |
V
Vente
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
2 967
-8.9%
64,46
191 251
USD
|
2 967
-8.9%
|
64,46
|
191 251
USD
|
|
2024-02-12 |
2024-02-12 |
V
Vente
|
Elghandour Rami
SEE REMARKS
Administrateur exécutif
|
11 169
-10.8%
64,46
719 948
USD
|
11 169
-10.8%
|
64,46
|
719 948
USD
|
|
2024-02-12 |
2024-02-09 |
V
Vente
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
3 688
-10.0%
63,40
233 811
USD
|
3 688
-10.0%
|
63,40
|
233 811
USD
|
|
2024-02-12 |
2024-02-09 |
V
Vente
|
Elghandour Rami
SEE REMARKS
Administrateur exécutif
|
13 886
-11.8%
63,40
880 340
USD
|
13 886
-11.8%
|
63,40
|
880 340
USD
|
|
2024-02-12 |
2024-02-08 |
V
Vente
|
Heery Christopher
CHIEF MEDICAL OFFICER
Dirigeant
|
3 456
-8.6%
62,29
215 290
USD
|
3 456
-8.6%
|
62,29
|
215 290
USD
|
|
2024-02-12 |
2024-02-08 |
V
Vente
|
Elghandour Rami
SEE REMARKS
Administrateur exécutif
|
13 010
-10.0%
62,29
810 451
USD
|
13 010
-10.0%
|
62,29
|
810 451
USD
|
|
2024-01-08 |
2024-01-04 |
V
Vente
|
Elghandour Rami
See Remarks
Administrateur exécutif
|
29 073
-32.6%
55,27
1 606 804
USD
|
29 073
-32.6%
|
55,27
|
1 606 804
USD
|
|
2024-01-08 |
2024-01-04 |
V
Vente
|
Gilson Michelle
Chief Financial Officer
Dirigeant
|
8 514
-34.3%
55,27
470 551
USD
|
8 514
-34.3%
|
55,27
|
470 551
USD
|
|
2024-01-08 |
2024-01-04 |
V
Vente
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
7 598
-29.8%
55,27
419 926
USD
|
7 598
-29.8%
|
55,27
|
419 926
USD
|
|
2023-12-19 |
2023-12-18 |
V
Vente
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
845
-9.8%
51,86
43 823
USD
|
845
-9.8%
|
51,86
|
43 823
USD
|
|
2023-12-19 |
2023-12-18 |
V
Vente
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
12 243
-58.6%
51,03
624 700
USD
|
12 243
-58.6%
|
51,03
|
624 700
USD
|
|
2023-12-19 |
2023-12-18 |
V
Vente
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
106 912
-83.7%
50,06
5 351 758
USD
|
106 912
-83.7%
|
50,06
|
5 351 758
USD
|
|
2023-12-18 |
2023-12-14 |
V
Vente
|
Carroll Jill
Administrateur non-exécutif
|
504 263
-20.3%
49,13
24 774 441
USD
|
504 263
-20.3%
|
49,13
|
24 774 441
USD
|
|
2023-08-07 |
2023-08-04 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
3 000
-27.8%
35,38
106 133
USD
|
3 000
-27.8%
|
35,38
|
106 133
USD
|
|
2023-07-05 |
2023-07-03 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
3 000
-27.8%
31,75
95 246
USD
|
3 000
-27.8%
|
31,75
|
95 246
USD
|
|
2023-06-02 |
2023-06-01 |
V
Vente
|
Carroll Jill
Administrateur non-exécutif
|
25 556
-1.0%
44,35
1 133 317
USD
|
25 556
-1.0%
|
44,35
|
1 133 317
USD
|
|
2023-06-02 |
2023-05-31 |
V
Vente
|
Elghandour Rami
See Remarks
Administrateur exécutif
|
2 600
-6.7%
44,27
115 099
USD
|
2 600
-6.7%
|
44,27
|
115 099
USD
|
|
2023-06-02 |
2023-05-31 |
V
Vente
|
Carroll Jill
Administrateur non-exécutif
|
315 164
-11.1%
41,50
13 079 306
USD
|
315 164
-11.1%
|
41,50
|
13 079 306
USD
|
|
2023-05-25 |
2023-05-25 |
V
Vente
|
Gilson Michelle
Chief Financial Officer
Dirigeant
|
6 000
-38.7%
42,77
256 616
USD
|
6 000
-38.7%
|
42,77
|
256 616
USD
|
|
2023-05-25 |
2023-05-24 |
V
Vente
|
Gilson Michelle
Chief Financial Officer
Dirigeant
|
150
-1.0%
41,64
6 246
USD
|
150
-1.0%
|
41,64
|
6 246
USD
|
|
2023-05-25 |
2023-05-24 |
V
Vente
|
Gilson Michelle
Chief Financial Officer
Dirigeant
|
8 554
-35.4%
42,47
363 288
USD
|
8 554
-35.4%
|
42,47
|
363 288
USD
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
|
3 804
-0.2%
46,15
175 555
USD
|
3 804
-0.2%
|
46,15
|
175 555
USD
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
|
6 485
-0.2%
46,15
299 283
USD
|
6 485
-0.2%
|
46,15
|
299 283
USD
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
|
370 612
-18.2%
45,00
16 677 540
USD
|
370 612
-18.2%
|
45,00
|
16 677 540
USD
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
|
631 932
-18.2%
45,00
28 436 940
USD
|
631 932
-18.2%
|
45,00
|
28 436 940
USD
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
Carroll Jill
Administrateur non-exécutif
|
6 485
-0.2%
46,15
299 283
USD
|
6 485
-0.2%
|
46,15
|
299 283
USD
|
|
2023-05-15 |
2023-05-11 |
V
Vente
|
Carroll Jill
Administrateur non-exécutif
|
631 932
-18.2%
45,00
28 436 940
USD
|
631 932
-18.2%
|
45,00
|
28 436 940
USD
|
|
2023-05-11 |
2023-05-10 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
2 197
-22.0%
45,18
99 266
USD
|
2 197
-22.0%
|
45,18
|
99 266
USD
|
|
2023-05-11 |
2023-05-09 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
500
-4.8%
45,00
22 500
USD
|
500
-4.8%
|
45,00
|
22 500
USD
|
|
2023-05-08 |
2023-05-05 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
1 200
-10.3%
45,00
54 002
USD
|
1 200
-10.3%
|
45,00
|
54 002
USD
|
|
2023-05-05 |
2023-05-03 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
2 600
-18.2%
43,56
113 243
USD
|
2 600
-18.2%
|
43,56
|
113 243
USD
|
|
2023-05-05 |
2023-05-03 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
400
-2.7%
42,72
17 086
USD
|
400
-2.7%
|
42,72
|
17 086
USD
|
|
2023-04-26 |
2023-04-24 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
20 000
-63.1%
40,00
800 068
USD
|
20 000
-63.1%
|
40,00
|
800 068
USD
|
|
2023-04-20 |
2023-04-19 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
15 642
-57.2%
35,01
547 661
USD
|
15 642
-57.2%
|
35,01
|
547 661
USD
|
|
2023-04-20 |
2023-04-18 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
6 000
-28.6%
35,00
210 000
USD
|
6 000
-28.6%
|
35,00
|
210 000
USD
|
|
2023-04-04 |
2023-04-03 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
402
-2.5%
31,17
12 531
USD
|
402
-2.5%
|
31,17
|
12 531
USD
|
|
2023-04-04 |
2023-04-03 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
2 598
-14.0%
30,63
79 589
USD
|
2 598
-14.0%
|
30,63
|
79 589
USD
|
|
2023-02-09 |
2023-02-09 |
V
Vente
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
6 966
-30.9%
30,77
214 333
USD
|
6 966
-30.9%
|
30,77
|
214 333
USD
|
|
2023-02-09 |
2023-02-09 |
V
Vente
|
Elghandour Rami
See Remarks
Administrateur exécutif
|
31 442
-44.8%
30,77
967 423
USD
|
31 442
-44.8%
|
30,77
|
967 423
USD
|
|
2023-02-07 |
2023-02-03 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
1 255
-100.0%
35,11
44 068
USD
|
1 255
-100.0%
|
35,11
|
44 068
USD
|
|
2023-01-05 |
2023-01-03 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
2 500
-100.0%
31,11
77 775
USD
|
2 500
-100.0%
|
31,11
|
77 775
USD
|
|
2022-12-27 |
2022-12-23 |
V
Vente
|
SANDELL SCOTT D
Large shareholder
|
195
-100.0%
31,67
6 176
USD
|
195
-100.0%
|
31,67
|
6 176
USD
|
|
2022-12-27 |
2022-12-23 |
V
Vente
|
SANDELL SCOTT D
Large shareholder
|
195
-100.0%
31,67
6 176
USD
|
195
-100.0%
|
31,67
|
6 176
USD
|
|
2022-12-22 |
2022-12-22 |
V
Vente
|
BASKETT FOREST
Large shareholder
|
1 628
-100.0%
31,45
51 207
USD
|
1 628
-100.0%
|
31,45
|
51 207
USD
|
|
2022-12-22 |
2022-12-21 |
V
Vente
|
Makhzoumi Mohamad
Large shareholder
|
179
-100.0%
30,74
5 502
USD
|
179
-100.0%
|
30,74
|
5 502
USD
|
|
2022-12-22 |
2022-12-21 |
V
Vente
|
SANDELL SCOTT D
Large shareholder
|
179
-100.0%
30,74
5 502
USD
|
179
-100.0%
|
30,74
|
5 502
USD
|
|
2022-12-14 |
2022-12-13 |
VP
Vente planifiée
|
Heery Christopher
Chief Medical Officer
Dirigeant
|
12 500
-100.0%
30,03
375 320
USD
|
12 500
-100.0%
|
30,03
|
375 320
USD
|
|
2022-06-23 |
2022-06-21 |
A
Achat
|
New Enterprise Associates 15, L.P.
Large shareholder
|
312 500
+4.9%
16,00
5 000 000
USD
|
312 500
+4.9%
|
16,00
|
5 000 000
USD
|
|
2022-02-10 |
2022-02-08 |
A
Achat
|
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
|
1 600 000
+369.3%
15,00
24 000 000
USD
|
1 600 000
+369.3%
|
15,00
|
24 000 000
USD
|
|
2022-02-10 |
2022-02-08 |
A
Achat
|
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
|
66 667
+2.0%
15,00
1 000 005
USD
|
66 667
+2.0%
|
15,00
|
1 000 005
USD
|
|
2022-02-09 |
2022-02-08 |
A
Achat
|
Novo Holdings A/S
Large shareholder
|
833 333
+26.2%
15,00
12 499 995
USD
|
833 333
+26.2%
|
15,00
|
12 499 995
USD
|
|
2022-02-09 |
2022-02-08 |
A
Achat
|
Carroll Jill
Administrateur non-exécutif
|
1 600 000
+369.3%
15,00
24 000 000
USD
|
1 600 000
+369.3%
|
15,00
|
24 000 000
USD
|
|
2022-02-09 |
2022-02-08 |
A
Achat
|
Carroll Jill
Administrateur non-exécutif
|
66 667
+2.0%
15,00
1 000 005
USD
|
66 667
+2.0%
|
15,00
|
1 000 005
USD
|
|